British corporate investigator Peter Humphrey and his wife Yu Yingzeng leave court yesterday. Photograph: Reuters/Aly Song

A British corporate investigator embroiled in GlaxoSmithKline’s Chinese corruption scandal has been sentenced to two-and-a-half years in prison for hi(...)

An internal court video shows British investigator Peter Humphrey inside Shanghai No 1 Intermediate  Court during his trial on Friday. Chinese prosecutors  charged Mr Humphrey and his American wife Yu Yingzeng with illegally obtaining private information. Photograph: Carlos Barria/Reuters

British corporate investigator Peter Humphrey and his American wife Yu Yingzeng went on trial on Friday at Shanghai No 1 Intermediate Court accused of(...)

China’s case against British investigator Peter Humphrey and his wife, Yu Yingzeng, has become a key piece in a long-running investigation into GlaxoSmithKline, whose China executives have been charged with orchestrating a widespread network of bribery to promote sales. Photograph: Reuters/Aly Song

Prosecutors in China have filed charges against British investigator Peter Humphrey and his US wife, the official Xinhua news agency said yesterday(...)

A Chinese national flag is seen in front of a GlaxoSmithKline office building in Shanghai. Photograph: Aly Song/Reuters

Confirmation last week from British drug-maker GlaxoSmithKline that it had received a secretly filmed sex tape of its former China chief, Mark Reilly,(...)

Chinese-American venture capitalist Charles Xue, who was detained several weeks ago on suspicion of soliciting prostitutes, appeared on the CCTV channel wearing handcuffs and a prison uniform. Photograph:  Reuters

China’s state media has shown jailed web commentator Charles Xue confessing to spreading irresponsible posts online, as the government steps up its ca(...)

Peter Humphrey and his former client, GSK. Photograph: Reuters

Chinese state television has broadcast a public confession by British corporate investigator Peter Humphrey, who has been held with his American wife (...)

Andrew Witty, GlaxoSmithKline Plc chief executive officer: he will hope his investors are concentrating on the numbers when he unveils the FTSE 100 giant’s second-quarter financial results at midday today.

GlaxoSmithKline chief executive Sir Andrew Witty will hope his investors are concentrating on the numbers when he unveils the FTSE 100 giant’s second-(...)